ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 2309 • 2019 ACR/ARP Annual Meeting

    Clinical Study of Peripheral Blood Lymphocyte Subsets in Patients with Rheumatoid Arthritis Complicated with Osteoporosis

    Ting Cheng1, Sheng-xiao Zhang 2, Xiao-qing Liu 1, Jia Wang 1, Chong Gao 3 and Xiao-feng Li 1, 1The Second Hospital of Shanxi Medical University, Taiyuan, China (People's Republic), 2The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China (People's Republic), 3Brigham and Women’s Hospital, Harvard Medical School, Boston

    Background/Purpose: Rheumatoid arthritis(RA) is an autoimmune disease mainly manifested by aggressive polyarthritis.The incidence of osteoporosis(OP) has risen and the risk of fracture has further increased…
  • Abstract Number: 2310 • 2019 ACR/ARP Annual Meeting

    Determinants of Cognitive Function in Rheumatoid Arthritis (RA) Patients

    Teresa Szlachetka1, Linda Li 2, Teresa Liu-Ambrose 2, Hui Xie 3, Eric Sayre 4 and Diane Lacaille 5, 1Arthritis Research Canada, University of British Columbia, Vancouver, BC, Canada, 2University of British Columbia, Vancouver, BC, Canada, 3Arthritis Research Canada and Simon Fraser University, Vancouver, BC, Canada, 4Arthritis Research Canada, Vancouver, BC, Canada, 5Arthritis Research Canada and University of British Columbia, Vancouver, BC, Canada

    Background/Purpose: Cognitive impairment (CI), or “brain fog” as rheumatoid arthritis (RA) patients often describe it, is prevalent in persons with RA and can significantly impact…
  • Abstract Number: 2311 • 2019 ACR/ARP Annual Meeting

    Association of Sexual Dysfunction and Depression in Rheumatoid Arthritis Female Patients

    Bruna Piola 1, Pedro Santos 2, Flávia Barros 2, Hugo Lima 2, Paulo Cerquinho 2, Rafael Caminha 2, Dennys Fagundes 2, Leia Andrade 2, Felipe Torres 2, Mariana Luna 2 and Laurindo Rocha Jr2, 1Instituto de Medicina Integral Professor Fernando Figueira -IMIP, Recife, Pernambuco, Brazil, 2Instituto de Medicina Integral Professor Fernando Figueira - IMIP, Recife, Pernambuco, Brazil

    Background/Purpose: Rheumatoid arthritis (RA) is a chronic disease that affects joints and is associated with many aspects of the patients´ lives, including sexual function and…
  • Abstract Number: 2312 • 2019 ACR/ARP Annual Meeting

    Lymphoproliferative Disorders in Patients with Rheumatoid Arthritis: Results from Japanese Multi-institutional Study Using Research Electronic Data Capture

    Suguru Honda1, Ryoko Sakai 2, Masako Majima 1, Naoko Konda 1, Hideto Takada 1, Kazuhiko Yamamoto 3, Tsutomu Takeuchi 4 and Masayoshi Harigai 1, 1Department of Rheumatology, Tokyo Women's Medical University School of Medicine, Shinjuku-ku, Tokyo, Japan, 2Department of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan, 3Riken Center for Integrative Medical Sciences, Kanagawa, Japan, 4Keio University School of Medicine, Tokyo, Japan

    Background/Purpose: The risk of lymphoma is higher among patients with rheumatoid arthritis (RA) compared to general populations 1. Methotrexate (MTX), the anchor drug for RA,…
  • Abstract Number: 2313 • 2019 ACR/ARP Annual Meeting

    Patients with Rheumatoid Arthritis Have a Higher Risk of Bipolar Disorder: A Systematic Review and Meta-analysis

    Patompong Ungprasert1, Nipith Charoenngam 2 and Ben Ponvilawan 2, 1Cleveland Clinic, Cleveland, OH, Bangkok, Thailand, 2Mahidol University, Bangkok, Thailand

    Background/Purpose: Patients with chronic autoimmune diseases may have a higher risk of psychiatric illness as a result of chronic neuro-inflammation and immune dysregulation. The current…
  • Abstract Number: 2314 • 2019 ACR/ARP Annual Meeting

    Improved Anxiety, Depression, and Emotional Distress for Rheumatoid Arthritis Patients Following the Completion of an Online Mental Health Intervention

    Caitlin Blaney1, Carol Hitchon 1, Ruth Ann Marrie 2, Corey Mackenzie 1, Pamela Holens 1 and Renée El-Gabalawy 2, 1University of Manitoba, Winnipeg, Canada, 2University of Manitoba, Winnipeg, MB, Canada

    Background/Purpose: Background: Anxiety and depression are common in people with rheumatoid arthritis (RA). These comorbidities are associated with worse disease outcomes including pain and functional…
  • Abstract Number: 2315 • 2019 ACR/ARP Annual Meeting

    Association of Rheumatic Autoimmune Disease, Including Rheumatoid Arthritis, with Post-Traumatic Stress Disorder but Not Traumatic Brain Injury in Veterans

    Biji Kurien 1, Calin Prodan 2 and Robert Scofield1, 1Oklahoma Medical Research Foundation, Oklahoma City, OK, 2Department of Neurology, University of Oklahoma Health Sciences Center, Oklahoma City, OK

    Background/Purpose: Autoimmune diseases, including rheumatoid arthritis (RA) and systemic lupus erythematosus, are 2- to 3-fold more common among those with post-traumatic stress disorder (PTSD) than…
  • Abstract Number: 2316 • 2019 ACR/ARP Annual Meeting

    National Trends in Hospitalizations and Mortality for Acute Myocardial Infarction in Patients with Rheumatoid Arthritis: Data from National Inpatient Sample 2010-2014

    Shraddha Jatwani1, Karan Jatwani 2, Bikramjit Bindra 3 and Karan Chugh 1, 1St. Vincent Evansville, Evansville, 2Mount Sinai West - St Luke’s Hospital, New York, 3Government Medical College & Hospital, Chandigarh, India

    Background/Purpose: Rheumatoid arthritis (RA) has been associated with increased cardiovascular mortality. More intensive treatment with a focus on “treat to target” strategies are being developed,…
  • Abstract Number: 2317 • 2019 ACR/ARP Annual Meeting

    Gut Dysbiosis Is Associated with Measures of Early Vascular Dysfunction in Patients with Rheumatoid Arthritis

    Michelle Ormseth1, Joseph Solus 1, Annette Oeser 1 and C. Michael Stein 1, 1Vanderbilt University Medical Center, Nashville

    Background/Purpose: Patients with rheumatoid arthritis (RA) have accelerated cardiovascular disease independent of traditional risk factors. Previous studies demonstrate that the gut microbiome is altered in…
  • Abstract Number: 2318 • 2019 ACR/ARP Annual Meeting

    Elevated Pro-inflammatory Lipid Mediators Associate with Low Paraoxonase 1 Activity in Patients with Rheumatoid Arthritis and Arthritic K/BxN Mice

    Christina Charles-Schoeman1, Jennifer Wang 2, Ani Shahbazian 2, Jeremy Papesh 2 and Srinivasa Reddy 2, 1University of California, Los Angeles, CA, 2UCLA Medical Center, Los Angeles

    Background/Purpose: Paraoxonase 1 (PON1) is a high density lipoprotein (HDL)-associated enzyme, which promotes the anti-oxidant and anti-inflammatory properties of HDL. We previously associated low PON1…
  • Abstract Number: 2319 • 2019 ACR/ARP Annual Meeting

    Are Vitamin D Metabolite Levels at Time of Diagnosis Associated with Long-term Severe Cardiovascular Events in Early Diagnosed Rheumatoid Arthritis Patients, Aggressively Treated During 10 Year Follow Up? Post-hoc Analyses of Observational Data from the CIMESTRA Cohort

    Mette Herly1, Kristian Stengaard-Pedersen 2, Kim Hørslev-Petersen 3, Merete Lund Hetland 4, Mikkel Østergaard 5, Robin Christensen 6, Brian Løgstrup 7, Peter Vestergaard 8, Peter Junker 9 and Torkell Ellingsen 10, 1Odense University Hospital, Odense C, Syddanmark, Denmark, 2Department of Rheumatology, Department of Clinical Medicine, Aarhus University Hospital, Aarhus University, Aarhus, Denmark, Aarhus, Denmark, 3Department of Rheumatology, King Christian X’s Hospital for Rheumatic Diseases Graasten, Denmark, Graasten, Denmark, 4DANBIO and Copenhagen Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Centre of Head and Orthopaedics, Rigshospitalet, Copenhagen, Denmark, 5Copenhagen Center for Arthritis Research, University of Copenhagen, Copenhagen, Denmark, 6Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital & Department of Rheumatology, Institute of Clinical Research, University of Southern Denmark, Odense University Hospital, Odense, Denmark, 7Aarhus University Hospital, Skejby, Aarhus, Denmark, 8Aalborg University Hospital, Aalborg, Denmark, 9Odense University Hospital, Odense, Denmark, 10Department of Rheumatology, Odense University Hospital, Denmark, Odense, Syddanmark, Denmark

    Background/Purpose: Cardiovascular disease is highly prevalent in Rheumatoid Arthritis (RA) and in non-RA subjects with low vitamin D levels. The aim of the present study…
  • Abstract Number: 2320 • 2019 ACR/ARP Annual Meeting

    Knowledge of Cardiovascular Disease Risk Among Patients with Rheumatoid Arthritis

    Juan Bande1, María Medina 1, Julia Sosa 1, María Kohan 1, Silvia Papasidero 1, José Caracciolo 1, Diana Klajn 1, Julio Wacker 1, Analía Alvarez 2, Romina Lim 2, Eduardo Kerzberg 3, Damaris Alvarez 3, Alejandra Trampuz 3, Gustavo Citera 4, Maria Correa 5, Analia Dellepiane 6, Adriana Perez Davila 7, Analía Verónica Bohr 7, Dora Pereira 8, Federico Giordano 8, Mónica Sacnun 9, Claudia Hartvig, 9, Maria Noelia Bersano 9, Mónica Díaz 10, Vanesa Cecilia Cruzat 11, Laura Raiti 12, Julia Demarchi 13, Iván Dario Remolina Rincón 13, Carolina Segura Escobar 13, Mariana Benegas 14, Etel Saturansky 14, Emma Civit 15, Federica Garignani 15, Gustavo Casado 16, Andrea M. Smichowski 16, Noel Agustin Callahuara Goiburu 17, Juan Arguello 17, Maria Paula Girard Bosch 18, Rosana Quintana 19, Bernardo A. Pons-Estel 19, Carla Gobbi 20, Darío Scublinsky 21, Mariana Salcedo 22, Maria de la Vega 23, Eliana Blanco 24, Hernán Maldonado Ficco 25, Lucía Degioanni 25, Nicolás Perez 26, Alejandro Martinez Muñoz 27 Silvina Mariana Rodriguez 28, Karin Kirmayr 29 and Sandra Petruzzelli30, 1Hospital General de Agudos Dr. E. Tornú, Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina, 2Hospital General de Agudos José M. Penna, Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina, 3Hospital Ramos Mejía, Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina, 4Instituto de Rehabilitación Psicofísica, Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina, 5Consultorios Reumatológicos Pampa, Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina, 6CEMEC, Casilda, Santa Fe, Argentina, 7Hospital de Rehabilitación M. Rocca, Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina, 8Hospital Zonal de Agudos Dr. Ricardo Gutiérrez, La Plata, Buenos Aires, Argentina, 9Hospital Provincial de Rosario, Rosario, Santa Fe, Argentina, 10Centro Traumatológico Bariloche, San Carlos de Bariloche, Rio Negro, Argentina, 11Clínica Bessone, Buenos Aires, Argentina, 12Clinica Bessone, Buenos Aires, Argentina, 13Hospital Británico, Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina, 14Sanatorio Mendez, Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina, 15OSEP. Universidad de Mendoza. F.C. Médicas, Ciudad de Mendoza, Argentina, 16Hospital Militar Central, Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina, 17Hospital General de Agudos B. Rivadavia, Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina, 18Instituto Médico Platense, La Plata, Argentina, 19Centro Regional de Enfermedades Autoinmunes y Reumáticas (CREAR), Grupo Oroño, Rosario, Argentina, 20CÁTEDRA DE CLÍNICA MÉDICA I, HOSPITAL CÓRDOBA, FACULTAD DE CIENCIAS MÉDICAS, UNIVERSIDAD NACIONAL DE CÓRDOBA, ARGENTINA, Cordoba, Argentina, 21Centros Médicos Ambulatorios SMG, Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina, 22Instituto de Cardiología, San Nicolás, Santa Fe, Argentina, 23CEIM Investigaciones Medicas, Buenos Aires, Argentina, 24Hospital General de Agudos Dr. Cosme Argerich, Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina, 25Hospital San Antonio de Padua, Río Cuarto, Cordoba, Argentina, 26Instituto de Investigaciones Médicas Alfredo Lanari, Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina, 27Hospital Municipal Dr. R. Larcade, San Miguel, Buenos Aires, Argentina, 28Hospital Municipal de Trauma y Emergencias Dr. Federico Abete, Malvinas Argentinas, Buenos Aires, Argentina, 29Hospital Zonal Bariloche, Bariloche, Argentina, 30Casa Hospital San Juan de Dios, La Plata, Buenos Aires, Argentina

    Background/Purpose: Patients with rheumatoid arthritis (RA) have a significantly higher risk of cardiovascular disease (CVD) than general population. The Heart Disease Fact Questionnaire (HDFQ-RA 1…
  • Abstract Number: 2321 • 2019 ACR/ARP Annual Meeting

    Subclinical Myocardial Dysfunction Assessed by Strain Imaging in Patients with Rheumatoid Arthritis and Spondyloarthritis

    Guillaume CLERFOND 1, Marc VILLEDON DE NAIDE 2, Clara ALLEMAND 3, Lucie ULMANN 3, Romain ESCHALIER 3, Martin SOUBRIER 4, Bruno Pereira 5 and Anne TOURNADRE6, 1CHU de Clermont Ferrand, Clermont Ferrand, 2CHU de Clermont Ferrand, Clermont -Ferrand, France, 3CHU de Clermont Ferrand, Clermont Ferrand, France, 4CHU Gabriel Montpied, Clermont Ferrand, Auvergne, France, 5CHU CLERMONT-FERRAND, CLERMONT-FERRAND, France, 6CHU de Clermont-Ferrand, Clermont-Ferrand, France

    Background/Purpose: Although cardiovascular (CV) risk and mortality are increased in rheumatoid arthritis (RA) and spondyloarthritis (SpA), mechanisms resulting in CV risk excess and stratification are…
  • Abstract Number: 2322 • 2019 ACR/ARP Annual Meeting

    Toward Cardiovascular Risk Stratification in Rheumatoid Arthritis: Use of Regression Tree Analyses to Evaluate Impact of Serum Biomarkers and Cardiovascular Risk Factors on Carotid Intima Media Thickness

    Kimberly Liang1, Yaming Li 1, Suresh Mulukutla 1, Steven Reis 1, Marc Levesque 1, Donald Jones 1, Rachel Gartland 1, Jennifer Avolio 1, Ali Hakim Shoushtari 1, Flordeliza Villanueva 1, Larry Moreland 1 and Douglas Landsittel 2, 1University of Pittsburgh, Pittsburgh, PA, 2University of Pittsburgh, Pittsburgh, RI

    Background/Purpose: Both traditional cardiovascular (CV) risk factors and disease-related factors contribute to the increased risk of cardiovascular disease (CVD) in rheumatoid arthritis (RA). Mechanisms of…
  • Abstract Number: 2323 • 2019 ACR/ARP Annual Meeting

    The Association Between Disease Activity with Coronary Microvascular Dysfunction in Rheumatoid Arthritis

    Sicong Huang 1, Zeling He 1, Daniel Solomon 2, Elena Massarotti 3, Charlotte Golnik 1, Thany Seyok 1, Seth Brownmiller 4, Tianrun Cai 3, Nicole Yang 3, Laurel Campbell 3, Leanne Barrett 3, Courtney Bibbo 3, Kenneth Pariser 3, Derrick Todd 3, Marcy Bolster 4, Marcelo Di Carli 3 and Katherine Liao1, 1Brigham and Women's Hospital, Boston, MA, 2Brigham and Women´s Hospital, Div. of Rheumatology, Immunology and Allergy, Boston, MA, 3Brigham and Women's Hospital, Boston, 4Massachusetts General Hospital, Boston, MA

    Background/Purpose: Inflammation accounts for much of the excess cardiovascular disease (CVD) in patients with rheumatoid arthritis (RA).  We hypothesize that increased systemic inflammation leads to…
  • « Previous Page
  • 1
  • …
  • 1092
  • 1093
  • 1094
  • 1095
  • 1096
  • …
  • 2607
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology